IM Cannabis (IMCC) Treasury Shares (2021 - 2022)

IM Cannabis' (IMCC) quarterly Treasury Shares came in at -$486223.9 in Q4 2022, up 7.14% year-on-year from -$453827.0 in Q4 2021, and up 3.92% quarter-over-quarter from -$506052.5 in Q3 2022.

IM Cannabis (IMCC) Treasury Shares (2021 - 2022) Analysis & Trends

IM Cannabis' Treasury Shares history runs 2 years deep, the most recent figure standing at -$486223.9 for Q4 2022.

  • On a quarterly basis, Treasury Shares rose 7.14% year-over-year to -$486223.9 in Q4 2022; TTM through Dec 2022 was -$486223.9, a 7.14% increase from a year earlier, with the FY2022 full-year figure at -$507649.6, up 3.61% from the prior year.
  • Treasury Shares rose to -$486223.9 in Q4 2022 per IMCC's latest filing, from -$506052.5 in the prior quarter.
  • Across five years, Treasury Shares topped out at -$486223.9 in Q4 2022 and bottomed at -$523601.8 in Q4 2021.
Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Treasury Shares (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - 62.52 Mn
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 107.00 Mn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 11.29 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 313.27 Mn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 5.44 Bn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 1.01 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn -
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn -
10 IM Cannabis 591,792.44 -193,562.09 1.03 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2022 -486,223.94
Dec 31, 2022 -486,223.94
Sep 30, 2022 -506,052.52
Sep 30, 2022 -506,052.52
Jun 30, 2022 -517,664.83
Jun 30, 2022 -517,664.83
Mar 31, 2022 -521,053.77
Mar 31, 2022 -521,053.77
Dec 31, 2021 -523,601.81
Dec 31, 2021 -523,601.81